Hologic Inc (LTS:0J5Q)
$ 79.62 0.08 (0.1%) Market Cap: 18.04 Bil Enterprise Value: 18.37 Bil PE Ratio: 23.87 PB Ratio: 3.59 GF Score: 85/100

Hologic Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 06:35PM GMT
Release Date Price: $46.84
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Okay, thank you, and good afternoon, everybody. I'm Jack Meehan, the life science, tools and diagnostics analyst here at Barclays and really pleased to be joined by Hologic team: CFO, Karleen Oberton; as well as Head of Investor Relations, Mike Watts.

Before kicking it off, we're going to start with 3 audience response questions, so please use the BlackBerrys.

Question #1, what do you view as Hologic's organic growth profile over the next 3 years?

(Voting)

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

And you'll give us the answer later.

Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications

Or not.

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Or not. Low to mid-single digits. Okay. Next question. Do you expect organic growth to accelerate from here and when?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot